TPA for stroke : the story of a controversial drug /

Mostrar otras versiones (1)

Without warning stroke can paralyze, blind, or kill. Some victims recover, but many do not and may even suffer another disabling or fatal attack. The drug known as tPA can drastically reduce the long-term disability associated with stroke, but despite its near-miraculous capabilities and the growing...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Zivin, Justin A.
Otros Autores: Simmons, John, 1949-
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Oxford University Press, 2011.
Temas:
Cerebrovascular disease > Chemotherapy > History.
Tissue plasminogen activator > Therapeutic use > History.
Stroke > history
Stroke > drug therapy
Tissue Plasminogen Activator > history
Fibrinolytic Agents > therapeutic use
Tissue Plasminogen Activator > therapeutic use
Accidents vasculaires cérébraux > Chimiothérapie > Histoire.
Activateur tissulaire du plasminogène > Emploi en thérapeutique > Histoire.
MEDICAL > Neurology.
Cerebrovascular disease > Chemotherapy
Tissue plasminogen activator > Therapeutic use
Electronic books.
History
Acceso en línea:Texto completo
Descripción
Sumario:Without warning stroke can paralyze, blind, or kill. Some victims recover, but many do not and may even suffer another disabling or fatal attack. The drug known as tPA can drastically reduce the long-term disability associated with stroke, but despite its near-miraculous capabilities and the growing support of most neurologists, it has been slow to win acceptance as the standard of care in emergency departments nationwide. tPA for Stroke chronicles how this remarkable drug came to be tested in stroke victims, its early years in development by the pharmaceutical giant Genentech, and its eventua.
Descripción Física:1 online resource (xiv, 191 pages)
Bibliografía:Includes bibliographical references and index.
ISBN:9780199780945
0199780943

Ejemplares similares